Home 2021-02-03T17:01:56+00:00

Klox Technologies

Klox is a private biomedical technology innovator that targets specific skin and soft tissue conditions by controlling the benefits of fluorescence generated energy to penetrate and manage the skin from within. The unique products we bring to the market stimulate the skin’s own biological processes and repair mechanisms, which demonstrate high safety and efficacy, helping clinicians improve patient outcomes without compromise.

Our technology induces Fluorescence Biomodulation (FB), which has shown to impact cellular signaling pathways in the skin. We research, develop, and partner solutions based on our fluorescence-generating technology, otherwise known as fluorescent light energy (FLE), for a growing population that is seeking more effective and less invasive options to improve their health.

Explore our Technology

Klox products are applied to the skin and activated by LED light for a short exposure period lasting under ten minutes.

Light interacts with light absorbing molecules (LAM) embedded within Klox’s topical product to generate fluorescent energy.

Klox is a medical device company that transforms lives through its innovative Fluorescence Biomodulation technology.  Read more.

About Us

Klox Technologies Inc. is a private regenerative medicine company, advancing the development of its Fluorescent light energy platform, also known as Fluorescence Biomodulation, for specific skin/soft tissue conditions and diseases. We believe that our dedication to providing healthcare professionals with novel and effective treatment solutions will allow patients to experience positive results without some of the side effects associated with existing stand of care treatments.


Klox invests in the development, innovation and delivery of launch-ready technology and products. To commercialize our Fluorescence Biomodulation technology, we rely on investment capital and long-term business partners with expertise in our therapeutic categories.
Please contact Business Development for partnering opportunities.

Trusted Collaborators

At Klox, we always strive to build and invest in our science, technology, and engineering expertise. To challenge the conventions of the industry, we extend our capabilities by collaborating with leading professionals and cutting-edge scientific facilities, wherever they may be. Our extended network is critical for maintaining vitality and scientific rigor in our mission to bring Fluorescence Biomodulation to patients in need.

News & Events

December 12, 2019

December 12, 2019

October 29, 2019

October 27-29, 2019

Targeting Mitochondria Congress – Berlin, Germany

October 22-23, 2019

The International Scar Club Meeting – Montpellier, France

October 8, 2019

Klox Technologies Inc. announces the appointment of Mr. Domenic Serafino and Dr. Richard Markoff to its board of directors – See Full Press Release here

October 4, 2019

Klox Technologies Inc. Announces Completion of the Acquisition of FB Dermatology – See Full Press Release here

September 26-28, 2019

September 23-25, 2019

The MedTech Conference – Boston, United States

August 30, 2019

August 19-22, 2019

Military Health System Research Symposium – Florida, United States

August 13, 2019

June 10-15, 2019

June 5-7, 2019

May 16-17, 2019

VetCon – Cork, Ireland

May 3-4, 2019

March 20-21, 2019

March 15-17, 2019

La Chirurgia Estetica– Florence, Italy

March 8, 2019

March 7, 2019

LumiHeal was granted the Canadian Medical Device License (MDL) for “the management of post-surgical closed wounds and to help in the prevention of hypertrophic scars and post-surgical wound complications in patients 18 years and older”

March 1, 2019

Fluorescence Biomodulation has been added to various sections in the Journal of Wound Care’s 2019 peer-reviewed International Consensus Document – Implementing TIMERS: the race against hard-to-heal wounds

February 26-27, 2019

Animal Health Investment Europe – London, England

February 2-7, 2019

SPIE Photonics West – San Francisco, USA

January 30, 2019

LumiHeal Newsletter – Updates On Our Lead Wound Care Product

January 20-22, 2019

Journées Cicatrisations – Paris, France

January 7-10, 2019

J.P. Morgan Healthcare Conference – San Francisco, USA

November 5-7, 2018

Wounds UK – Harrogate, UK

November 4, 2018

September 24-26, 2018

The MedTech Conference – Philadelphia, USA

September 12-14, 2018

July 2, 2018

Klox announces positive top-line results from a pivotal study of Phovia™ for the management of Canine Deep Pyoderma – See Full Press Release

June 13-14, 2018

June 4-7, 2018

May 9-11, 2018

May 2-3, 2018

April 25-29, 2018